Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20846646 | 0.96 | MEN1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846642 | 0.94 | MEN1 (0.37) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846647 | 0.93 | DHFR (0.34) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846650 | 0.92 | MEN1 (0.35) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846668 | 0.92 | MEN1 (0.38) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846561 | 0.91 | MEN1 (0.34) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846759 | 0.91 | GRM5 (0.35) | MAPTTDP1 | |
| SCHEMBL20846625 | 0.89 | CASP3 (0.31) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL20846645 | 0.88 | MEN1 (0.38) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL20846653 | 0.87 | HPGD (0.37) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472564-B2 | Delayed fluorescence compound and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-11-12 | — | — | US | disclosed |
| US-20190093009-A1 | DELAYED FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472564-B2 | Delayed fluorescence compound and organic electroluminescent device using the same | SLCO4C1, LEF1, SLCO2A1 | MEN1 3186/4885KMT2A 2759/4885ALDH1A1 2768/4885 |
| US-20190093009-A1 | DELAYED FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLCO4C1, LEF1, SLCO2A1 | MEN1 3186/4885KMT2A 2759/4885ALDH1A1 2768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.